DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli

BMC Biotechnology

Volumn 10, Issue , 2010, Pages

  Liu, Yamei ^a   Stepanov, Victor G ^a   Strych, Ulrich ^a   Willson, Richard C ^a,b   Jackson, George W ^c   Fox, George E ^a  

^a University of Houston   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c BIOTEX INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMERS; BACTERIAL CELLS; BIOMEDICAL RESEARCH; CELLULAR CONSTITUENTS; DELETION MUTANTS; DNAZYME; E. COLI; ECONOMICAL METHODS; EXISTING METHOD; IN-VIVO; LARGE-SCALE PRODUCTION; LIQUID SOLIDS; NOVEL METHODS; OVER-EXPRESSION; PROTEOLYTICUS; RRNA GENES; SEQUENCE ENCODING; SMALL RNA; SPECIFIC CAPTURE; TOXIC CHEMICALS;

AFFINITY CHROMATOGRAPHY; BACTERIOLOGY; CYTOLOGY; DNA; ESCHERICHIA COLI; GENE ENCODING; MANUFACTURE; RECOVERY; SCAFFOLDS;

RNA;

BACTERIAL RNA; OLIGODEOXYNUCLEOTIDE; PLASMID VECTOR; RECOMBINANT RNA; RNA 5S; DEOXYRIBOZYME; RNA; RNA, RECOMBINANT;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERIAL CELL; BACTERIUM TRANSFORMATION; CHIMERA; DELETION MUTANT; ESCHERICHIA COLI; GENE EXPRESSION; GENE SEQUENCE; NONHUMAN; PROMOTER REGION; RNA ISOLATION; VIBRIO; BIOSYNTHESIS; FERMENTATION; GENETICS; METABOLISM;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; VIBRIO PROTEOLYTICUS;

DNA, CATALYTIC; ESCHERICHIA COLI; FERMENTATION; PROMOTER REGIONS, GENETIC; RNA; RNA, RIBOSOMAL, 5S;

EID: 78649714067     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-10-85     Document Type: Article

References (58)

1. Kaur G, Roy I. Therapeutic applications of aptamers. Expert Opin Investig Drugs 2008, 17:43-60. 10.1517/13543784.17.1.43, 18095918.
2. Pai SS, Ellington AD. Using RNA aptamers and the proximity ligation assay for the detection of cell surface antigens. Methods Mol Biol 2009, 504:385-398. full_text, 19159107.
3. Lee C, Dhillon J, Wang MY, Gao Y, Hu K, Park E, Astanehe A, Hung MC, Eirew P, Eaves CJ, Dunn SE. Targeting YB-1 in HER-2 overexpressing breast cancer cells induces apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in mice. Cancer Res 2008, 68:8661-8666. 10.1158/0008-5472.CAN-08-1082, 18974106.
4. Chu TC, Twu KY, Ellington AD, Levy M. Aptamer mediated siRNA delivery. Nucleic Acids Res 2006, 34:e73. 10.1093/nar/gkl388, 1474074, 16740739.
5. Chalk AM, Warfinge RE, Georgii-Hemming P, Sonnhammer EL. siRNAdb: a database of siRNA sequences. Nucleic Acids Res 2005, (33 Database):D131-134. 540090, 15608162.
6. Sefah K, Phillips JA, Xiong X, Meng L, Van Simaeys D, Chen H, Martin J, Tan W. Nucleic acid aptamers for biosensors and bio-analytical applications. Analyst 2009, 134:1765-1775. 10.1039/b905609m, 19684896.
7. Dausse E, Da Rocha Gomes S, Toulme JJ. Aptamers: a new class of oligonucleotides in the drug discovery pipeline?. Curr Opin Pharmacol 2009, 9:602-607. 10.1016/j.coph.2009.07.006, 19717337.
8. Winkler WC, Nahvi A, Roth A, Collins JA, Breaker RR. Control of gene expression by a natural metabolite-responsive ribozyme. Nature 2004, 428:281-286. 10.1038/nature02362, 15029187.
9. Barrick JE, Corbino KA, Winkler WC, Nahvi A, Mandal M, Collins J, Lee M, Roth A, Sudarsan N, Jona I, Wickiser JK, Breaker RR. New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control. Proc Natl Acad Sci USA 2004, 101:6421-6426. 10.1073/pnas.0308014101, 404060, 15096624.
10. Kanzaki LI, Ornelas SS, Arganaraz ER. RNA interference and HIV-1 infection. Rev Med Virol 2008, 18:5-18. 10.1002/rmv.553, 17764099.
11. Lea MA. Recently identified and potential targets for colon cancer treatment. Future Oncol 2010, 6:993-1002. 10.2217/fon.10.53, 20528236.
12. Pfeffer S, Baumert TF. Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection. Gastroenterol Clin Biol
13. Thoma C, Bogner E. Short hairpin RNAs specific to human cytomegalovirus terminase subunit pUL89 prevent viral maturation. Antivir Ther 2010, 15:391-400. 10.3851/IMP1536, 20516558.
14. Gebhardt K, Shokraei A, Babaie E, Lindqvist BH. RNA aptamers to S-adenosylhomocysteine: kinetic properties, divalent cation dependency, and comparison with anti-S-adenosylhomocysteine antibody. Biochemistry 2000, 39:7255-7265. 10.1021/bi000295t, 10852725.
15. McCauley TG, Hamaguchi N, Stanton M. Aptamer-based biosensor arrays for detection and quantification of biological macromolecules. Anal Biochem 2003, 319:244-250. 10.1016/S0003-2697(03)00297-5, 12871718.
16. Rajendran M, Ellington AD. Selecting nucleic acids for biosensor applications. Comb Chem High Throughput Screen 2002, 5:263-270.
17. Alekseev OM, Richardson RT, Alekseev O, O'Rand MG. Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP. Reprod Biol Endocrinol 2009, 7:45. 10.1186/1477-7827-7-45, 2686705, 19439102.
18. Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 2002, 169:5196-5201.
19. Coemans B, Takahashi Y, Berberich T, Ito A, Kanzaki H, Matsumura H, Saitoh H, Tsuda S, Kamoun S, Sagi L, Swennen R, Terauchi R. High-throughput in planta expression screening identifies an ADP-ribosylation factor (ARF1) involved in non-host resistance and R gene-mediated resistance. Mol Plant Pathol 2008, 9:25-36.
20. Wei L, Liu X, Cao C. [RNA interference and its application in inhibiting HIV-1 infection]. Sheng Wu Gong Cheng Xue Bao 2005, 21:516-519.
21. Sagan SM, Nasheri N, Luebbert C, Pezacki JP. The efficacy of siRNAs against hepatitis C virus is strongly influenced by structure and target site accessibility. Chem Biol 2010, 17:515-527. 10.1016/j.chembiol.2010.04.011, 20534349.
22. Majumder P, Gomes KN, Ulrich H. Aptamers: from bench side research towards patented molecules with therapeutic applications. Expert Opin Ther Pat 2009, 19:1603-1613. 10.1517/13543770903313746, 19852719.
23. Rusconi CP, Roberts JD, Pitoc GA, Nimjee SM, White RR, Quick G, Scardino E, Fay WP, Sullenger BA. Antidote-mediated control of an anticoagulant aptamer in vivo. Nat Biotechnol 2004, 22:1423-1428. 10.1038/nbt1023, 15502817.
24. Mi J, Zhang X, Rabbani ZN, Liu Y, Reddy SK, Su Z, Salahuddin FK, Viles K, Giangrande PH, Dewhirst MW, Sullenger BA, Kontos CD, Clary BM. RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Mol Ther 2008, 16:66-73. 10.1038/sj.mt.6300320, 17912235.
25. Sarraf-Yazdi S, Mi J, Moeller BJ, Niu X, White RR, Kontos CD, Sullenger BA, Dewhirst MW, Clary BM. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer. J Surg Res 2008, 146:16-23. 10.1016/j.jss.2007.04.028, 17950331.
26. Chan MY, Cohen MG, Dyke CK, Myles SK, Aberle LG, Lin M, Walder J, Steinhubl SR, Gilchrist IC, Kleiman NS, Vorchheimer DA, Chronos N, Melloni C, Alexander JH, Harrington RA, Tonkens RM, Becker RC, Rusconi CP. Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease. Circulation 2008, 117:2865-2874. 10.1161/CIRCULATIONAHA.107.745687, 18506005.
27. Lago BD, Birnbaum J, Demain AL. Fermentation process for double-stranded ribonucleic acid, an interferon inducer. Appl Microbiol 1972, 24:430-436. 376536, 4562479.
28. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990, 185:60-89. full_text, 2199796.
29. Lopez PJ, Dreyfus M. The lacZ mRNA can be stabilised by the T7 late mRNA leader in E. coli. Biochimie 1996, 78:408-415. 10.1016/0300-9084(96)84747-X, 8915530.
30. Ponchon L, Dardel F. Recombinant RNA technology: the tRNA scaffold. Nat Methods 2007, 4:571-576. 10.1038/nmeth1058, 17558412.
31. Ponchon L, Beauvais G, Nonin-Lecomte S, Dardel F. A generic protocol for the expression and purification of recombinant RNA in Escherichia coli using a tRNA scaffold. Nat Protocols 2009, 4:947-959.
32. Kanaya S. Prokaryotic type 2 RNases H. Methods Enzymol 2001, 341(Pt A):377-394.
33. Inoue H, Hayase Y, Iwai S, Ohtsuka E. Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett 1987, 215:327-330. 10.1016/0014-5793(87)80171-0, 2438160.
34. Lima WF, Mohan V, Crooke ST. The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity. J Biol Chem 1997, 272:18191-18199. 10.1074/jbc.272.29.18191, 9218455.
35. Pitulle C, Hedenstierna KO, Fox GE. A novel approach for monitoring genetically engineered microorganisms by using artificial, stable RNAs. Appl Environ Microbiol 1995, 61:3661-3666. 167667, 7487004.
36. D'Souza LM, Larios-Sanz M, Setterquist RA, Willson RC, Fox GE. Small RNA sequences are readily stabilized by inclusion in a carrier rRNA. Biotechnol Prog 2003, 19:734-738.
37. Pitulle C, D'Souza L, Fox GE. A low molecular weight artificial RNA of unique size with multiple probe target regions. Syst Appl Microbiol 1997, 20:133-136.
38. Tucker DL, Karouia F, Wang J, Luo Y, Li TB, Willson RC, Fofanov Y, Fox GE. Effect of an artificial RNA marker on gene expression in Escherichia coli. Appl Environ Microbiol 2005, 71:4156-4159. 10.1128/AEM.71.7.4156-4159.2005, 1168998, 16000839.
39. Breaker RR. Natural and engineered nucleic acids as tools to explore biology. Nature 2004, 432:838-845. 10.1038/nature03195, 15602549.
40. Breaker RR. Making Catalytic DNAs. Science 2000, 290:2095-2096. 10.1126/science.290.5499.2095, 11187837.
41. Breaker RR, Joyce GF. A DNA enzyme with Mg(2+)-dependent RNA phosphoesterase activity. Chem Biol 1995, 2:655-660. 10.1016/1074-5521(95)90028-4, 9383471.
42. Breaker RR, Joyce GF. A DNA enzyme that cleaves RNA. Chem Biol 1994, 1:223-229. 10.1016/1074-5521(94)90014-0, 9383394.
43. Breaker RR. DNA enzymes. Nat Biotechnol 1997, 15:427-431. 10.1038/nbt0597-427, 9131619.
44. Blum H, Beier H, Gross H. Improved silver staining of plant-proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987, 8:93-99.
45. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. 1989, Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2.
46. Girish V, Vijayalakshmi A. Affordable image analysis using NIH Image/ImageJ. Indian J Cancer 2004, 41:47.
47. Rinehart J, Krett B, Rubio MA, Alfonzo JD, Soll D. Saccharomyces cerevisiae imports the cytosolic pathway for Gln-tRNA synthesis into the mitochondrion. Genes Dev 2005, 19:583-592. 10.1101/gad.1269305, 551578, 15706032.
48. Antony T, Thomas T, Shirahata A, Thomas TJ. Selectivity of polyamines on the stability of RNA-DNA hybrids containing phosphodiester and phosphorothioate oligodeoxyribonucleotides. Biochemistry 1999, 38:10775-10784. 10.1021/bi990180t, 10451373.
49. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001, 58:244-258. 10.1007/PL00000852, 11289306.
50. Venkiteswaran S, Vijayanathan V, Shirahata A, Thomas T, Thomas TJ. Antisense recognition of the HER-2 mRNA: effects of phosphorothioate substitution and polyamines on DNA.RNA, RNA.RNA, and DNA.DNA duplex stability. Biochemistry 2005, 44:303-312. 10.1021/bi0485272, 15628872.
51. Xaplanteri MA, Petropoulos AD, Dinos GP, Kalpaxis DL. Localization of spermine binding sites in 23S rRNA by photoaffinity labeling: parsing the spermine contribution to ribosomal 50S subunit functions. Nucleic Acids Res 2005, 33:2792-2805. 10.1093/nar/gki557, 1129027, 15897324.
52. Bonaccio M, Credali A, Peracchi A. Kinetic and thermodynamic characterization of the RNA-cleaving 8-17 deoxyribozyme. Nucleic Acids Res 2004, 32:916-925. 10.1093/nar/gkh250, 373389, 14963261.
53. Cruz RP, Withers JB, Li Y. Dinucleotide junction cleavage versatility of 8-17 deoxyribozyme. Chem Biol 2004, 11:57-67.
54. Liu Z, Mei SH, Brennan JD, Li Y. Assemblage of signaling DNA enzymes with intriguing metal-ion specificities and pH dependences. J Am Chem Soc 2003, 125:7539-7545. 10.1021/ja035208+, 12812493.
55. Schlosser K, Gu J, Lam JC, Li Y. In vitro selection of small RNA-cleaving deoxyribozymes that cleave pyrimidine-pyrimidine junctions. Nucleic Acids Res 2008, 36:4768-4777. 10.1093/nar/gkn396, 2504313, 18644842.
56. Zhang X, Potty AS, Jackson GW, Stepanov V, Tang A, Liu Y, Kourentzi K, Strych U, Fox GE, Willson RC. Engineered 5S ribosomal RNAs displaying aptamers recognizing vascular endothelial growth factor and malachite green. J Mol Recognit 2009, 22:154-161. 10.1002/jmr.917, 19195013.
57. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159. 10.1016/0003-2697(87)90021-2, 2440339.
58. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protocols 2006, 1:581-585.